Table 2.
Proudfoot | Hart | Scherrmann | Sawada | Jones | This study | |
---|---|---|---|---|---|---|
Total Patients | 73 | 219 | 30 | 30 | 375 | 451 |
Female | 29 | NA | 8 | 11 | 101 | |
Male | 42 | NA | 22 | 19 | 350 | |
Age | NA | |||||
Mean | 38 | – | 45 | 38.3 | 29 | |
Median | – | – | – | 25 | ||
Range (IQR) | 16–81 | 17–75 | – | 1–87 | 12–93 (20–34) | |
Post ingestion time to blood sampling | NA | NA | ||||
Median | – | 11 | ||||
Range (IQR) | 24–360 h | 0.5–335 (4.5–26.0) | ||||
Number surviving | 45 (62%) | 109 (49.7%) | 9 (30%) | 10 (33%) | 134 (35.7%) | 186 (39.6%) |